Credit rating agency S&P Global Ratings has warned that Australian private health insurers face a growing risk to their creditworthiness if they cannot manage healthcare inflation without driving policyholders toward lower tiers of cover or out of the system entirely. The September 6, 2026, report – titled “The Medical Claims Inflation Challenge: Can Australian Health Insurers Preserve Margins Without Losing Members?” – does not constitute a rating action but identifies margin management as an emerging credit differentiator. “The creditworthiness of insurers that are unable to effectively manage these challenges may weaken,” the report states. S&P’s analysts describe the challenge as structural rather than cyclical, and one that will compound over time: “These dynamics are likely here to stay and may become a credit differentiator over time.”
The central finding is a sustained divergence between claims growth and premium growth. The government approved an average premium rate increase of approximately 4.41% from April 1, 2026 – a decade-high figure – yet S&P found it fell below the level of health insurance inflation for the fourth consecutive year. S&P said claims growth has outpaced premium growth in each of the past three years, citing data from the Australian Prudential Regulation Authority’s (APRA) quarterly private health insurance statistics.
S&P, citing APRA data, said total insurer-funded benefits reached approximately $28 billion in the year to June 2026, up nearly 30% from $21.6 billion for the year ended June 2021. Private health insurers recorded insurance revenue of $8.523 billion in the March 2026 quarter, against insurance service expenses of $8.088 billion, producing an insurance service result of $392 million, down from $468 million in the prior quarter.
S&P identifies the cost drivers as structural: increased utilisation of elective procedures, rising wages for healthcare workers, greater treatment complexity, longer average hospital stays, higher costs for medical devices and prostheses, and an ageing member base. Private hospitals have reported financial pressures severe enough to result in service reductions and facility closures in certain specialties, including maternity and mental health services. S&P notes these trends “reduce flexibility in price negotiations with providers and increase the likelihood that future premium increases will need to more closely reflect medical cost trends.” Independent actuarial firm Finity Consulting found that the 4.41% headline premium increase masked “widening divergences by tier, product status, and insurer strategy,” with structural margin pressures increasingly visible across hospital products, according to its State of the 2026 PHI Market report.
S&P flags a dynamic that aggregate membership figures can conceal. While hospital coverage has remained above 45% of the population – 12,790,111 people, representing 45.8% of the Australian population, held hospital treatment cover as of March 31, 2026 – S&P said consumers are increasingly managing affordability by trading down within the system rather than exiting it. The proportion of insured Australians in the top Gold category has fallen from about 40% in December 2020 to below 30%, according to the Department of Health, Disability and Ageing’s private health insurance reform data. The Actuaries Institute puts the March 2026 Gold product share at 30%, down from 43% when product tiering was introduced in April 2019. In June 2025, 360,000 fewer Gold-tier policies were held than in the March 2020 quarter, covering 743,000 fewer Australians, despite a total increase of 640,000 hospital policies over the same period.
S&P warns that this product mix shift carries a distinct margin risk: “Product downgrades could dilute margins even if headline policyholder numbers continue to rise.” The report further cautions that “a continued decline in the number of policyholders with Gold coverage may also make that product unsustainable in the future.” The scale of the shift has been acknowledged at the insurer level. Bupa APAC CEO Nick Stone said approximately 440,000 Bupa customers had downgraded their cover over the past two years, equivalent to almost one in 10 customers. Private Healthcare Australia CEO Dr Rachel David has also highlighted the implications for Gold cover, noting that it includes mental health and maternity care. “If we can’t offer an affordable solution to those things, why would anyone under the age of 50 have private health insurance?” she said.
S&P outlines four strategies it expects to differentiate insurers that successfully manage margin pressure from those that do not.
S&P identifies a shift from paying claims to managing care utilisation, including Hospital in the Home models where clinically appropriate treatments are delivered outside traditional hospital settings. The Department of Health, Disability and Ageing’s Private Health Sector Reform Consultation Paper 1, released July 2, 2026, proposes expanding these arrangements and asks insurers to incorporate them into products for the 2027 premium round.
S&P notes insurers are developing modular, life-stage-aligned products and expanding ancillary benefits – including mental health support and chronic disease management – with the explicit objective of “optimising the composition of the policyholder pool rather than merely increasing premium income.”
The report identifies advanced analytics as “a source of competitive differentiation and a key determinant of operating performance across the sector,” enabling reduction in claims leakage, provider network optimisation, and a shift toward preventive care engagement.
S&P describes investment in virtual healthcare platforms, real-time biometric monitoring, and machine learning tools designed to identify high-risk members before they generate high-cost claims as a “critical pathway to preserve margins in a regulated environment.”
At the insurer level, FY2026 results provide examples of how major operators are responding to claims-cost pressure. nib Holdings reported underlying claims inflation had moderated to 4.1%, excluding the contribution from NSW bed-rate changes, while insurance revenue grew 6.4% to $3,012.7 million. Medibank CEO David Koczkar said the company’s claims payout ratio remained above the industry average.
S&P’s conclusion is unambiguous on competitive structure: “We expect scale advantages will likely become increasingly important, supporting larger incumbents with better expense advantages, more diversified policyholder bases, stronger negotiating leverage, and more advanced data capabilities.” Smaller insurers, S&P warns, may find it harder to absorb cost inflation while maintaining competitive pricing – and their creditworthiness may weaken. The number of private health insurers fell to 28 from 29 in the September 2025 quarter, adding to the consolidation trend against which S&P sees scale advantages becoming increasingly important.
For brokers, this carries a direct panel implication. Selecting a smaller fund on premium competitiveness alone, without assessing its capacity to absorb sustained margin pressure over a three-to-five-year horizon, may expose clients and brokers alike to insurer financial resilience risk that is not visible at the point of renewal. The Insurance Brokers Code Compliance Committee’s 2025 Annual Data Report found 5,417 breaches of the Insurance Brokers Code of Practice across the year, affecting 14,842 clients, with renewal timeframe failures the most significant area of non-compliance – meaning the renewal conversation, where fund selection and coverage adequacy are live questions, remains the profession's most documented point of failure.
S&P’s report is clear that an immediate profitability crisis is unlikely given the sector’s current balance-sheet strength. But its framing of disciplined pricing, provider engagement, product innovation, and data capability as the margin preservation levers – rather than premium increases alone – signals that how each insurer deploys those tools over the next several years will determine both their competitive position and their credit standing.
